Page 1 of Clinical Trials for Teva Pharmaceutical Industries [SPONSOR-COLLABORATORS], 139 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
ADAGIO Follow Up Study: Evaluation of the Long-Term Effects of Rasagiline in Parkinson's Disease Subjects
Last Updated: January 24, 2012
Condition(s): Parkinson's Disease
2
Active, not recruiting
Homoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene Mutation
Last Updated: May 3, 2012
Condition(s): Chronic Myeloid Leukemia
3
Active, not recruiting
Open Label Study of Subcutaneous Homoharringtonine (Omacetaxine Mepesuccinate) in Patients With Advanced CML
Last Updated: May 3, 2012
Condition(s): Chronic Myeloid Leukemia
4
Terminated
Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas
Last Updated: May 20, 2011
Condition(s): Glioblastoma Multiforme; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Anaplastic Mixed Oligoastrocytoma
5
Completed
A Randomized Placebo Controlled Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Disease
Last Updated: January 10, 2012
Condition(s): Parkinson's Disease
6
Completed
Azilect + Antidepressant Chart Review
Last Updated: November 30, 2010
Condition(s): Serotonin Syndrome
7
Completed
A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of Melanoma
Last Updated: October 14, 2010
Condition(s): Parkinson's Disease; Malignant Melanoma
8
Completed
Comparative Bioavailability of Myfenax® and CellCept® in Kidney Transplant Patients
Last Updated: October 19, 2011
Condition(s): Stable Renal Transplant Recipients
9
Completed
Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline
Last Updated: April 11, 2011
Condition(s): Relapse Remitting Multiple Sclerosis
10
Completed
Multicenter Trial for Adults With Partial Seizures
Last Updated: March 15, 2011
Condition(s): Epilepsy
11
Completed
BRAVO Study: Laquinimod Double Blind Placebo Controlled Study in RRMS Patients With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)
Last Updated: January 24, 2012
Condition(s): Multiple Sclerosis
12
Active, not recruiting
An Open Label Extension of the LAQ/5062 and LAQ/5063 Studies to Assess the Long Term Safety and Tolerability of Laquinimod 0.6mg in RRMS Patients
Last Updated: March 14, 2012
Condition(s): Relapsing Remitting Multiple Sclerosis
13
Suspended
A Multinational, Randomized, Double-blind, Parallel-group, Placebo-controlled Study Assessing the Safety and Tolerability
Last Updated: December 14, 2011
Condition(s): Relapsing Multiple Sclerosis
14
Not yet recruiting
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Last Updated: May 17, 2012
Condition(s): Asthma
15
Active, not recruiting
A Study to Evaluate the Long-term Safety, Tolerability and Effect of Daily Oral Laquinimod 0.6 mg on Disease Course in Subjects With Relapsing Multiple Sclerosis
Last Updated: March 14, 2012
Condition(s): Relapsing Multiple Sclerosis
16
Active, not recruiting
Copaxone® Study to Follow Patients From the First Original Study for Safety and Effectiveness.
Last Updated: February 24, 2012
Condition(s): Multiple Sclerosis
17
Active, not recruiting
A Study in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) to Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate (GA) Injection 40 mg Administered Three Times a Week Compared to Placebo
Last Updated: April 10, 2012
Condition(s): Relapsing Remitting Multiple Sclerosis
18
Recruiting
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Last Updated: May 17, 2012
Condition(s): Asthma
19
Completed
Study to Evaluate Early Glatiramer Acetate Treatment in Delaying Conversion to CDMS of Subjects Presenting With CIS
Last Updated: April 4, 2011
Condition(s): Multiple Sclerosis
20
Completed
A Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study.
Last Updated: April 8, 2011
Condition(s): Parkinson's Disease

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Teva+Pharmaceutical+Industries

Page 1 of Clinical Trials for Teva Pharmaceutical Industries [SPONSOR-COLLABORATORS], 139 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About